ICU Medical opened higher at $179.20, compared with its previous close of $178.26. In the last trading session, the stock traded between $176.80 and $179.95. It showed a sideways intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in ICU Medical is now worth
$ 73.17
Resulting in a loss of
$ 26.83 (26.83%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 3 Analysts
Buy
100%
Hold
0%
Sell
0%
Markets Today
Today's Change
$-0.97 (-0.54%)
Day High
$179.95
Day Low
$176.80
Day Open
$179.20
Prev Close
$178.26
Volume
2,33,143
1W Return
2.61%
1M Return
8.14%
3M Return
-2.61%
6M Return
42.20%
1Y Return
23.79%
Fundamentals
Market Cap ($ Mn)
4,434
PE Ratio
147.13
PB Ratio
2.03
PEG Ratio
-
ROE
0.04%
ROCE
2.42%
EPS (TTM)
$1.07
Investment Returns
1 Week
2.61%
1 Month
8.14%
3 Months
-2.61%
6 Months
42.20%
9 Months
20.01%
Financials
Quarterly
All values in $ Mn
548.9
Jun 25
537.0
Sep 25
540.7
Dec 25
530.2
Mar 26
551.7
Jun 26
560.4
Sep 26
Updates
6Nov
Keybanc maintains overweight on ICU Medical, raises price target to $189
Keybanc analyst Brett Fishbin raised the price target to $189. The previous price target was set at $187. The firm maintained an Overweight rating on the stock.
6 days ago
6Nov
ICU Medical Q3 FY26 adjusted EPS rises 20% to $2.44 on margin gains
Revenue rose 4% reported to $556 million with 5% organic growth. Adjusted EPS increased 20% YoY to $2.44 driven by margin expansion. IV Systems business grew 11% to record sales; Vital Care declined 10%. Free cash flow hit $83 million, enabling $80 million debt repayment. Net leverage reduced to below 2 times; full-year CapEx guidance cut to $75 million.
7 days ago
27Aug
ICU Medical to attend Wells Fargo and Morgan Stanley healthcare conferences
ICU Medical to hold fireside chats at Wells Fargo and Morgan Stanley healthcare conferences. Wells Fargo event takes place September 9-10, 2026, in Boston. Morgan Stanley conference scheduled for September 15, 2026, in New York. Live webcasts and archived replays available via investor relations site.
2mo ago
7Aug
ICU Medical Q2 Results: EPS beats estimates, guidance raised
ICU Medical Inc delivered a strong second quarter with EPS of $2.37, beating the $1.91 estimate. Revenue of $551.700 million also surpassed forecasts. The company raised its FY26 adjusted EPS guidance to $8.60-$9.00, citing strong Infusion Systems performance.
3mo ago
23Jul
ICU Medical schedules Q2 2026 earnings call for August 6
ICU Medical Inc has set August 6, 2026, as the date for its second quarter 2026 earnings release and subsequent conference call. The event will provide insights into the company's performance in the infusion systems sector. Investors can participate via phone or webcast.
3mo ago
15Jun
BTIG initiates coverage on ICU Medical with Buy rating
BTIG analyst Sam Eiber initiated coverage on ICU Medical Inc with a Buy rating and a price target of $170. The target suggests an upside from the previous closing price of $142.20.
